MA-BRIGHTCOVE
15.4.2024 15:01:27 CEST | Business Wire | Press release
Brightcove (NASDAQ: BCOV), the world’s most trusted streaming technology company, today announced the launch of its new player platforms for Roku, Samsung and LG Smart TVs. The launch of the new Software Development Kits (SDKs) has unlocked advanced features within Brightcove’s industry-leading player framework, including content protection, monetization, and analytics reporting capabilities. Designed to reduce the cost and speed of high-quality app development, media companies can more effectively target the Smart TV platforms fueling media growth while delivering a consistent, engaging premium viewer experience.
“Brightcove is committed to helping media companies deliver engaging and world-class reliable streaming experiences while reducing the costs traditionally associated with launching and running an OTT service," said Scott Levine, Chief Product Officer at Brightcove. “Our comprehensive platform enables media companies to benefit from out-of-the-box functionality and deliver premium app experiences with features previously only available in bespoke custom app development - at a fraction of the cost. "
Brightcove developed the SDKs with advertising needs in mind, supporting client-side and server-side ad insertion (CSAI, SSAI) and integrating them with digital advertising partners. Brightcove’s Roku SDK also complies with the Roku Advertising Framework (RAF), facilitating the certification process for customers. Brightcove’s Smart TV SDKs improve media handling and offer sophisticated content security capabilities, including multi-format DRM support, playback rights restrictions, and HDCP Fallback, seamlessly enabling secure delivery of premium content across all platforms.
Brightcove’s industry-leading Insights solutions also come pre-integrated. These insights, driven by the usage of the Smart TV SDKs, allow media companies to optimize ad breaks, improve player performance, identify content performance trends, pinpoint the cause of streaming quality issues, and measure impacts on viewer engagement, all to inform and enrich content, monetization and distribution strategies. The Smart TV SDKs automatically collect and report the session details impacting viewer satisfaction at scale, providing a clearer picture of overall streaming service performance and ensuring better viewer experiences.
In concert with the launch of the Smart TV SDKs, Brightcove has brought together a collection of the best video app developers to deliver options for media companies looking to meet viewers wherever they are. Partners include:
- Accedo – a global video solutions provider powering some of the world’s most impactful and engaging video-centric experiences. Accedo offers quick launch and simplified management with their Accedo One platform, or fully customizable solutions for companies looking to truly differentiate their video app experiences.
- Applicaster – helps content owners, OTT providers, and publishers connect with their audiences and drive business performance. The company’s Zapp platform is the industry’s most innovative no/low-code app management platform designed to give businesses the control, agility, and data they need to grow.
- Appsfactory – a paramount European digital agency boasting an illustrious 14-year history of crafting and deploying successful digital products and solutions.
- Arx.net/SoEasyTV – an established OTT applications provider that has developed and maintains multiple tailor-made OTT applications for large Pay TV Service Providers that support all platforms and operate with different video backend platforms. SoEasyTV OTT applications are a white-label solution that provides powerful functionalities, flexibility and a common user experience across all connected devices.
- Enveu – an end-to-end OTT technology solutions provider to build, launch, manage and grow a video streaming business across 12+ platforms, dedicated to helping media publishers and content creators.
- Pulselive – digital partner to some of the biggest names in sports, creating and powering digital experiences that engage millions of sports fans every day via digital products, including websites, mobile applications and emerging technologies.
- Spyrosoft BSG – Spyrosoft BSG (formerly known as Better Software Group) is revolutionizing digital media consumption by offering modern solutions tailored to the needs of content distributors such as broadcasters, media agencies, telecommunications companies and sports organizations.
- Robosoft Technologies – a proven digital transformation partner with a track record of crafting 10+ leading OTT streaming platforms enjoyed by millions across the globe.
- TV2Z – a global supplier of premium cloud-based OTT services that builds and launches streaming solutions across multiple devices and operators.
The Smart TV SDKs add to Brightcove’s already leading players (which currently service Web, Android, Android TV, Fire TV, iOS, iPad OS, and tvOS platforms) to propel media companies to be able to meet their audiences on any device.
For more information, visit Brightcove.com.
About Brightcove Inc.
Brightcove creates the world’s most reliable, scalable, and secure streaming technology solutions to build a greater connection between companies and their audiences, no matter where they are or on which devices they consume content. In more than 60 countries, Brightcove’s intelligent video platform enables businesses to sell to customers more effectively, media leaders to stream and monetize content more reliably, and every organization to communicate with team members more powerfully. With two Technology and Engineering Emmy® Awards for innovation, uptime that consistently leads the industry, and unmatched scalability, we continuously push the boundaries of what video can do. Follow Brightcove on LinkedIn, X, Facebook, Instagram, Threads, and YouTube. Visit Brightcove.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240415787309/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Consortium Led by Axelspace Selected for Japan’s Space Strategy Fund Project “Technology to Enhance Capability of Next Generation Earth Observation Satellites”30.3.2026 01:35:00 CEST | Press release
~ Creating Climate Solutions and New Market Opportunities through Source-Specific CO2 Emission and Uptake Monitoring via Satellite Constellation and Aircraft ~ Axelspace Corporation, Meisei Electric Co., Ltd., ANA HOLDINGS INC., and JIJ Inc. are pleased to announce that their jointly proposed technology development project has been selected for Japan Aerospace Exploration Agency (JAXA)’s Space Strategy Fund under the theme “Technology to Enhance Capability of Next Generation Earth Observation Satellites.” This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260323044518/en/ Conceptual Diagram of the project. Under this Space Strategy Fund initiative, spectrometers will be newly developed and demonstrated in orbit. In the future, the project envisions the establishment of a satellite constellation capable of observations at different times of the day. Project Summary (Planned) Technology Development Theme: Technology to Enhance Cap
Incyte Announces New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativa at the 2026 American Academy of Dermatology (AAD) Annual Meeting28.3.2026 20:00:00 CET | Press release
Phase 3 data from the STOP-HS program demonstrate povorcitinib’s substantial and durable clinical efficacy through Week 54 in patients with moderate to severe hidradenitis suppurativa (HS). Through Week 54, clinically meaningful and durable responses were observed across all groups in both STOP-HS1 and STOP-HS2, with up to 71.4% of patients achieving HiSCR50. Improvements in clinical responses across high stringent thresholds were observed, with up to 57% of participants achieving HiSCR75 and up to 29% of participants achieving HiSCR100. Povorcitinib treatment led to consistent reductions across key inflammatory lesion types, with full resolution (ANdT=0) achieved in up to 20% of patients. Additionally, clinically meaningful improvements in quality-of-life measures, including skin pain and fatigue, were observed at Week 54. The overall safety profile of povorcitinib through 54 weeks is consistent with previously reported data, and both doses were well tolerated. Incyte (Nasdaq:INCY) to
Takeda’s Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care28.3.2026 20:00:00 CET | Press release
About 70% of patients treated with zasocitinib achieved clear or almost clear skin (sPGA 0/1) at week 16 in Phase 3 plaque psoriasis studies A significantly greater PASI 75 response rate versus placebo was observed as early as week 4 Safety profile consistent with Phase 2b studies with no new safety signals identified Takeda(TSE:4502/NYSE:TAK)today announced new data from the two pivotal Phase 3studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO).1 Presented as a late-breaking abstract at the 2026 American Academy of Dermatology (AAD) Annual Meeting, these data show that convenient once-daily oral zasocitinib demonstrated rapid and durable skin clearance with a safety profile consistent with Phase 2b studies.1,2 “Our goal in psoriasis treatment is clear or almost clear skin, and previously this has been achieved primarily with injectable therapies,” said Melinda Gooderham,
AAD 2026: Late-Breaking Nemolizumab Data Demonstrate Clinically Meaningful Benefits for Children Aged 2 to 11 With Moderate-to-Severe Atopic Dermatitis28.3.2026 16:00:00 CET | Press release
Pharmacokinetics, safety and efficacy clinical study data show that nemolizumab achieved clinically meaningful reductions in skin lesions and itch through Week 16, which were sustained up to a year in children aged 2 to 11 with moderate-to-severe atopic dermatitis1 These findings reinforce the previously established safety and efficacy of nemolizumab in adults and adolescents with moderate-to-severe atopic dermatitis, for which it is approved by multiple global regulatory authorities2,3 Up to 25% of children are affected by atopic dermatitis, and currently there are limited approved treatment options for children living with moderate-to-severe atopic dermatitis4,5 Galderma (SIX: GALD) today announced new phase II data showing that nemolizumab was well tolerated and effective in children (aged 2 to 11 years) with moderate-to-severe atopic dermatitis, with a clinically meaningful and sustained reduction in skin lesions and itch for up to a year.1 Results will be presented in a late-break
Angelalign Technology (6699.HK)Releases 2025 Results: Passion for Clinical Excellence Drives Worldwide Growth27.3.2026 20:56:00 CET | Press release
Angelalign Technology Inc. (6699.HK) (“Angel” or the “Company”) released its financial results for fiscal year 2025. During the reporting period, the Company continued to do well in both the global and China markets. Total case volume was 532,400, which increased 48.1%, revenue was USD 370.3 million, which increased 37.8%, and adjusted net profit was USD 43.8 million, which increased 63.0%. The results were driven by Angel’s passion for clinical excellence and its open and inclusive culture that empowers talented people to work together to meet customer needs, the Company said. Fox Hu, CEO of Angel, stated: “The clear aligner industry is complex and multidisciplinary. It requires top-tier technical and operational talent along with seamless collaboration among professionals from diverse geographies. Angel’s open and inclusive culture attracts professionals who share a passion for clinical excellence and a dedication to bringing outstanding products and services to customers. This melti
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom